Kymera Therapeutics, Inc. (KYMR)

88.07 +1.14 (+1.31%) USD  |  NASDAQ  |  Apr 21, 16:00
88.04 -0.03 (-0.03%) After-Hours: 20:00
More

Kymera Therapeutics Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Indivior Pharmaceuticals, Inc. Upgrade
Structure Therapeutics, Inc. Upgrade